Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - streptococcus equi as cell free extract; clostridium tetani uf toxoid; thiomersal - misc. vaccines or anti sera - streptococcus equi as cell free extract vaccine-microbial active 0.0 p; clostridium tetani uf toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - strangles | tetanus | tetanus vaccination

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - streptococcus equi; thiomersal - misc. vaccines or anti sera - streptococcus equi vaccine-microbial active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - strangles | vaccine | equine rotavirus

Australia - English - Department of Health (Therapeutic Goods Administration)

ortho-clinical diagnostics australia pty ltd - ct798 - streptococcus ivds - sofia s. pneumoniae fia employs immunofluorescence for qualitative detection of streptococcus pneumoniae antigen in urine specimens of patients with pneumonia and in cerebral spinal fluid (csf) specimens of patients with meningitis. test results are to be used as an aid in diagnosis of both pneumococcal pneumonia and pneumococcal meningitis. a negative result does not preclude infections with streptococcus pneumoniae. test results are to be used in conjunction with information obtained from the patient?s clinical evaluation and other diagnostic procedures. this test is intended for professional point of care and laboratory use.

Australia - English - Department of Health (Therapeutic Goods Administration)

cepheid holdings pty ltd - ct798 - streptococcus ivds - the cepheid xpert gbs is a qualitative in vitro diagnostic test designed to detect group b streptococcus (gbs) dna from vaginal/rectal swab specimens, using pcr) with. xpert gbs assay testing is indicated for rapid identification of antepartum and intrapartum gbs colonization.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - lipoteichoic acid from biofilm adhesion component of streptococcus uberis, strain 5616 - immunologicals for bovidae - cattle - for active immunisation of healthy cows and heifers to reduce the incidence of clinical intramammary infections caused by streptococcus uberis, to reduce the somatic cell count in streptococcus uberis positive quarter milk samples and to reduce milk production losses caused by streptococcus uberis intramammary infections.

Australia - English - Department of Health (Therapeutic Goods Administration)

in vitro technologies pty ltd - ct798 - streptococcus ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to streptococcus bacteria in nucleic acid extracted from whole blood and cerebrospinal fluid (csf) and in rectovaginal swabs.

Australia - English - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct798 - streptococcus ivds - the panther fusion gbs assay is an automated in vitro diagnostic test utilising real-time pcr for detection of group b streptococcus dna from either lim or carrot enrichment broth cultures of vaginal/rectal swabs from antepartum women following 18-24 hours incubation.

Australia - English - Department of Health (Therapeutic Goods Administration)

qiagen pty ltd - ct798 - streptococcus ivds - ivds for the detection of streptococcus dna from human clinical samples

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - ct798 - streptococcus ivds - the revogene? gbs ds assay performed on the revogene? instrument is a qualitative in vitro diagnostic test designed to detect group b streptococcus (gbs) dna from vaginal/rectal swabs obtained from pregnant women. the revogene gbs ds assay utilizes automated sample processing and real-time polymerase chain reaction (pcr) to detect a cfb gene sequence specific to the streptococcus agalactiae genome. revogene gbs ds assay is indicated for the identification of intrapartum gbs colonization and does not provide susceptibility results.it is not intended to diagnose or monitor treatment of gbs infection. culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.

Australia - English - Department of Health (Therapeutic Goods Administration)

edwards group pty ltd - ct798 - streptococcus ivds - the immuview? s. pneumoniae antigen test is intended for diagnosis of streptococcus pneumoniae infections by detection of urinary antigens or antigens in cerebrospinal fluid (csf). the test is a lateral flow test also known as a lateral flow immunochromatographic assay.